← Back to Clinical Trials
Recruiting Phase 4 NCT07221019

NCT07221019 Single Shot Exparel vs Catheters in Lower Extremity Trauma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07221019
Status Recruiting
Phase Phase 4
Sponsor George Washington University
Condition Fracture Dislocation of Ankle Joint
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-09-12
Primary Completion 2028-08-11

Trial Parameters

Condition Fracture Dislocation of Ankle Joint
Sponsor George Washington University
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-12
Completion 2028-08-11
Interventions
BupivacaineExparel + Bupivacaine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will compare the use of single-shot Exparel, a long-acting local anesthestic, with the use of catheters that deliver a continuous flow of the short-acting local anesthetic ropivacaine. The comparison will be done in patients who receive preoperative adductor and sciatic nerve blocks prior to orthopedic surgery for traumatic lower extremity injury. The patients' pain will then be monitored for up to 72 hours after injection, measuring every 12 hours after injection until the 72-hour mark. Opioid consumption (measured in morphine milligram equivalents) will also be tracked over this time period.

Eligibility Criteria

Inclusion Criteria: * Closed lower extremity orthopedic injury * Opioid naive patients * No other significant surgical injuries on admission as determined by study physician Exclusion Criteria: * Allergy to local anesthetics * Multiple traumatic injuries * Weight less than 60 kg * Prior opioid use or risk of increased pain control needs as determined by PI * Chronic opioid use * Open fractures * Plastic surgery needed for complete closure * Patient has intraoperative cardiac arrest

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology